Trinity生物科技公共 TRIB 深 滬
等待開盤 07-18 09:30:00 美东时间
0.7301
-0.015
-1.97%
華盛通- 最 高0.7448
- 今 開0.7207
- 成交量 3.46万股
- 最 低 0.712
- 昨 收 0.7448
- 總市值 1360.32万
- 52周最高 3.39
- 市盈率 靜 --
- 換手率 0.19%
- 52周最低 0.48
- 委 比 99.65%
- 總股本 1863.20万
- 歷史最高 139.20
- 量 比 0.45
- 振 幅 4.40%
- 歷史最低 0.48
- 每 手 1
- 風險率 0.46%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Royal Bank of Canada announces Japanese Yen NVCC subordinated debenture issue
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, July 10, 2025 /CNW/ - Royal Bank of Canada (TSX: RY) (NYSE: RY) today announced a private ...
07-11 06:00
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS
PHILADELPHIA, July 10, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, THQ, THW and NYSE American: FAX, FCO, VFL), announced to...
07-11 04:17
Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround
Trinity Biotech expects to achieve Adjusted EBITDA positivity in Q2 2025 and cash flow positivity from Q3 onwards, following operational restructuring and cost reductions. The company highlights key developments, including rollout of upgraded diabetes care and HIV test products, progress on innovative tests for preeclampsia and prostate cancer, and advancements in its next-generation CGM solution. Q1 2025 revenue was $7.6m, with Q2 and Q3 expecte...
07-01 13:00
NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
NEW YORK, June 30, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of co...
07-01 05:55
Allspring Closed-End Funds Declare Monthly Distributions
CHARLOTTE, N.C., June 27, 2025 /PRNewswire/ -- The Allspring Income Opportunities Fund (NYSE American: EAD), the Allspring Multi-Sector Income Fund (NYSE American: ERC), and the Allspring Ut...
06-27 20:30
Trinity Biotech shares are trading higher after the company received World Health Organization approval for the offshored and outsourced manufacturing of its TrinScreen HIV rapid test.
Trinity Biotech shares are trading higher after the company received World Heal...
06-24 20:06
Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation
Trinity Biotech receives WHO approval for offshore and outsourced manufacturing of its TrinScreen™ HIV rapid test, supporting its financial turnaround and sustainable growth. The move is expected to improve gross margins, reduce fixed costs, and enhance supply chain agility. The new manufacturing model will be implemented in Q3 2025 as part of the company's broader strategy to streamline operations and focus on innovation and market expansion.
06-24 12:00
NEUBERGER BERMAN MUNICIPAL FUND ANNOUNCES MONTHLY DISTRIBUTION
NEW YORK, June 16, 2025 /PRNewswire/ -- Neuberger Berman Municipal Fund Inc. (NYSE American: NBH) (the "Fund") has announced a distribution declaration of $0.05417 per share of common stock....
06-17 04:30
NEUBERGER BERMAN ENERGY INFRASTRUCTURE AND INCOME FUND ANNOUNCES MONTHLY DISTRIBUTION
NEW YORK, May 30, 2025 /PRNewswire/ -- Neuberger Berman Energy Infrastructure and Income Fund Inc. (NYSE American: NML) (the "Fund") has announced a distribution declaration of $0.0584 per s...
05-31 04:30
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS
PHILADELPHIA, May 30, 2025 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE: ASGI) (NYSE: THQ) (the "Funds" or individually the "Fund"), today announced that the Funds pa...
05-31 04:17
